Metabolomics

Dataset Information

0

Macrophage-mediated antibiotic evasion and competitive dominance of mcr-3-carrying Escherichia coli


ABSTRACT:

Mobile colistin resistance (mcr) genes undermine the efficacy of last-line polymyxin antibiotics, and the global prevalence of mcr-3 continues to rise despite reduced colistin use. Here, we show that mcr-3-positive Escherichia coli (E. coli) confers a survival advantage by reprogramming macrophage immunity. MCR-3-mediated lipid A modification blunted TLR4-NF-kappaB signaling, suppressed macrophage reactive oxygen species (ROS) generation, and delayed phagosome-lysosome fusion, allowing mcr-3-positive strains to evade intracellular killing. Integrated transcriptomic and metabolomic analyses revealed extensive immunometabolic rewiring in infected macrophages, including altered glycerophospholipid metabolism and iron homeostasis. Consistently, mcr-3 enhanced bacterial tolerance to ferrous iron stress, likely mitigating host-induced ferroptotic damage. In a mouse co-infection model, mcr-3-positive strains outcompeted isogenic mcr-3-negative strains under antibiotic treatment without any difference in antibiotic susceptibility in vitro. These findings reveal a dual-action mechanism that mcr-3 endows E. coli with both antibiotic resistance and host immune suppression, enabling persistence under antibiotic pressure and highlighting the long-term threat of mcr-3 dissemination even in the absence of polymyxin use.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase, Liquid Chromatography MS - positive - reverse-phase

PROVIDER: MTBLS13550 | MetaboLights | 2026-05-30

REPOSITORIES: MetaboLights

Similar Datasets

2020-10-23 | E-MTAB-9277 | biostudies-arrayexpress
2020-07-01 | GSE153553 | GEO
2019-06-13 | GSE132637 | GEO
2014-09-11 | E-GEOD-55662 | biostudies-arrayexpress
2024-11-07 | GSE281216 | GEO
| phs001260 | dbGaP
2014-09-11 | GSE55662 | GEO
2021-07-15 | PXD025088 | Pride
2019-08-27 | GSE135946 | GEO
2024-03-19 | PXD044383 | Pride